|
Market Closed -
Nasdaq
04:00:00 2026-09-14 pm EDT
|
5-day change | 1st Jan Change | ||
| 381.50 USD | +1.10% |
|
-12.75% | +16.56% |
| Sep. 14 | Amgen Gets FDA Approval to Reduce Monitoring Time for First Two Imdelltra Doses | MT |
| Sep. 14 | Amgen Receives FDA Approval for Reduced Monitoring Time for First Two Doses of Imdelltra | CI |
| Market Cap | 206B 179B 169B 153B 287B 19,768B 289B 2,014B 776B 10,028B 775B 758B 31,882B | P/E 2026 * |
24.1x | P/E 2027 * | 21.6x |
|---|---|---|---|---|---|
| Enterprise Value | 248B 215B 203B 184B 345B 23,745B 347B 2,419B 932B 12,046B 930B 910B 38,295B | EV / Sales 2026 * |
6.36x | EV / Sales 2027 * | 6.02x |
| Free-Float |
99.77% | Yield 2026 * |
2.64% | Yield 2027 * | 2.79% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMGN | Delayed | |
CBOE
| AMGN | Real-time | |
|
Tradegate
| AMG | Real-time | |
|
Boerse Muenchen
| AMG | Real-time | |
|
Xetra
| AMG | Delayed | |
|
Mexican S.E.
| AMGN * | End-of-day quote | |
|
London S.E.
| 0R0T | Delayed | |
|
Wiener Boerse
| AMGN | End-of-day quote | |
|
Borsa Italiana
| 1AMGN | End-of-day quote | |
|
CBOE
| Real-time | ||
|
Berne S.E.
| 000907582 | End-of-day quote | |
|
Börse Stuttgart
| AMG | Delayed | |
|
CBOE
| 0R0T | Real-time | |
|
Deutsche Boerse AG
| AMG | Delayed | |
|
Santiago S.E.
| AMGN | End-of-day quote | |
|
Santiago S.E.
| AMGNCL | End-of-day quote |
Last Transcript: Amgen Inc.
| 1 day | +1.10% | ||
| 1 week | -12.75% | ||
| Current month | -11.25% | ||
| 1 month | -8.12% | ||
| 3 months | +7.40% | ||
| 6 months | +4.18% | ||
| Current year | +16.56% |
| 1 week | 376.76 |  | 395.55 |
| 1 month | 376.76 | | 447.03 |
| Current year | 318.21 | | 447.03 |
| 1 year | 269.77 | | 447.03 |
| 3 years | 249.7 | | 447.03 |
| 5 years | 198.64 | | 447.03 |
| 10 years | 133.64 | | 447.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 2012-04-30 |
| Director of Finance/CFO | 62 | 2010-05-12 | |
Paul Burton
CTO | Chief Tech/Sci/R&D Officer | 57 | 2023-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 2012-12-31 |
Tyler Jacks
BRD | Director/Board Member | 65 | 2011-12-31 |
Robert Eckert
BRD | Director/Board Member | 71 | 2011-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/1/26 | Other | Chief Financial Officer | 34,061 | 0.0063% | ||
| 8/13/26 | Exercice | Executive/Senior Manager | 3,756 | 0.0007% | ||
| 8/7/26 | Free | Director | 85 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.10% | -12.75% | +38.03% | +45.44% | 204B | |
| +2.02% | -0.96% | +50.69% | +92.40% | 994B | |
| +0.28% | -3.24% | +49.57% | +62.65% | 640B | |
| +1.81% | +2.07% | +19.89% | +70.38% | 454B | |
| +5.00% | +2.21% | +36.64% | +39.24% | 337B | |
| +1.68% | -9.20% | +15.25% | +24.87% | 261B | |
| +3.81% | +0.93% | +3.05% | +12.39% | 246B | |
| +1.43% | -6.21% | -19.49% | -58.94% | 190B | |
| +1.87% | -3.04% | +27.81% | +89.26% | 178B | |
| 0.00% | -2.57% | +16.13% | -18.83% | 158B | |
| Average | +1.78% | -4.42% | +23.76% | +35.89% | 366.28B | |
| Weighted average by Cap. | +1.53% | -3.16% | +32.71% | +53.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.94B 33.74B 31.84B 28.89B 54.19B 3,732B 54.58B 380B 147B 1,893B 146B 143B 6,019B | 40.23B 34.86B 32.9B 29.85B 55.99B 3,856B 56.39B 393B 151B 1,956B 151B 148B 6,219B |
| Net income | 8.69B 7.53B 7.11B 6.45B 12.09B 833B 12.18B 84.88B 32.71B 423B 32.64B 31.92B 1,343B | 9.36B 8.11B 7.66B 6.95B 13.03B 897B 13.12B 91.43B 35.23B 455B 35.16B 34.39B 1,447B |
| Net Debt | 41.49B 35.95B 33.92B 30.78B 57.73B 3,976B 58.15B 405B 156B 2,017B 156B 152B 6,413B | 35.82B 31.03B 29.29B 26.57B 49.84B 3,433B 50.2B 350B 135B 1,741B 135B 132B 5,536B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-14 | $381.50 | +1.10% | 2,714,697 |
| 26-09-11 | $377.35 | -1.34% | 2,272,874 |
| 26-09-10 | $382.47 | -2.25% | 3,431,980 |
| 26-09-09 | $391.27 | -0.48% | 2,922,839 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
Select your edition
All financial news and data tailored to specific country editions
